A Clinical Trial of MK-4646 With Bictegravir/Emtricitabine/Tenofovir Alafenamide and Dolutegravir in Healthy Adult Participants (MK-4646)
Clinical trial NCT07532304 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07532304
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-11
- Primary completion
- 2026-07-21
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.